UV-induced retinal proteome changes in the rat model of age-related macular degeneration  by Kraljević Pavelić, Sandra et al.
Biochimica et Biophysica Acta 1852 (2015) 1833–1845
Contents lists available at ScienceDirect
Biochimica et Biophysica Acta
j ourna l homepage: www.e lsev ie r .com/ locate /bbad isUV-induced retinal proteome changes in the rat model of age-related
macular degenerationSandra Kraljević Pavelić a,b,⁎, Marko Klobučar a,b, Mirela Sedić a,b, Vedran Micek c, Peter Gehrig d,
Jonas Grossman d, Krešimir Pavelić a,b, Božidar Vojniković e,⁎⁎
a University of Rijeka, Department of Biotechnology, Radmile Matejčić 2, HR-51000 Rijeka, Croatia
b University of Rijeka, Centre for high-throughput technologies, Radmile Matejčić 2, HR-51000 Rijeka, Croatia
c The Institute for Medical Research and Occupational Health, Ksaverska cesta 2, POB 291, HR-10001 Zagreb, Croatia
d Functional Genomics Center Zürich, University of Zurich/ETH Zurich, Winterthurerstrasse 190, CH-8057 Zürich, Switzerland
e University of Applied Sciences Velika Gorica, Zagrebačka cesta 5, Velika Gorica 10410, Croatia⁎ Correspondence to: S.K. Pavelić, University of Rijeka
Radmile Matejčić 2, 51000 Rijeka, Croatia.
⁎⁎ Corresponding author.
E-mail address: sandrakp@biotech.uniri.hr (S. Kraljevi
http://dx.doi.org/10.1016/j.bbadis.2015.06.006
0925-4439/© 2015 Elsevier B.V. All rights reserved.a b s t r a c ta r t i c l e i n f oArticle history:
Received 13 March 2015
Received in revised form 29 May 2015
Accepted 8 June 2015
Available online 10 June 2015
Keywords:
Age-related macular degeneration
UV irradiation
Oxidative stress
Interphotoreceptor matrix
Retinal pigment epithelium
ProteomicsAge-related macular degeneration (AMD) is characterized by irreversible damage of photoreceptors in the cen-
tral posterior part of the retina, called themacula and is themost common cause of vision loss in those aged over
50. A growing body of evidence shows that cumulative long-termexposure toUV radiationmay beharmful to the
retina and possibly leads to AMD irrespective of age. In spite of many research efforts, cellular and molecular
mechanisms leading to UV-induced retinal damage and possibly retinal diseases such as AMDare not completely
understood. In the present studywe explored damagemechanisms accounting for UV-induced retinal phototox-
icity in the rats exposed to UVA and UVB irradiation using a proteomics approach. Our study showed that UV ir-
radiation induces profound changes in the retinal proteomes of the rats associated with the disruption of energy
homeostasis, oxidative stress, DNA damage response and structural and functional impairments of the
interphotoreceptor matrix components and their cell surface receptors such as galectins. Two small leucine-
rich proteoglycans, biglycan and lumican, were identiﬁed as phototoxicity biomarkers associated with UV-
induced disruption of interphotoreceptor matrix (IPM). In addition, UVB induced activation of Src kinase,
which could account for cytoskeletal rearrangements in the retinawas observed at the proteomics level. Pharma-
cological intervention either to target Src kinase with the aim of preventing cytoskeletal rearrangements in the
retinal pigment epithelium (RPE) and neuronal retina or to help rebuild damaged IPMmay provide fresh avenues
of treatment for patients suffering from AMD.
© 2015 Elsevier B.V. All rights reserved.1. Introduction
Age-related macular degeneration (AMD) is a complex form of ocu-
lar disease characterized by the irreversible damage of photoreceptors
in the central posterior part of the retina or macula responsible for
sharp and central vision, adjoining retinal pigment epithelium (RPE)
and Bruch membrane [1]. The manifestation of this disease increases
proportionally with aging, and is considered a major cause of blindness
among people older than 65 [2]. Consequently, AMD has increased inci-
dence in highly industrialized countries considering the general trend of
prolonged life expectancy [3,4]. Based on the histological and patholog-
ical features, there are two distinct forms of advanced disease stage: dry
(non-neovascular or atrophic) and wet (neovascular). The dry form is
more common and encompasses more than 85% of all AMD cases. It is, Department of Biotechnology,
ć Pavelić).characterized by the accumulation of cellular debris or drusen under
the retina and retinal pigment epithelium causing gradual vision loss.
Over the years, this form can progress to late stage geographic atrophy
(GA) and lead to severe vision damage [5]. The remaining 15% refers
to the neovascular form of diseasewhich is a result of choroidal neovas-
cularization (CNV). This process includes development and growth of
abnormal blood vessels beneath the retina causing scarring and leakage
of blood and ﬂuid. It results in permanent damage of light-sensitive
photoreceptor cells leading to severe central vision loss and total blind-
ness [5]. Currently, there is no effective way of treatment and preven-
tion for the atrophic form of age-related macular degeneration. For the
neovascular form, there could be applied treatments with anti-
angiogenic agents that can slow down the progression of the disease
[6,7]. Similar to other age-dependent diseases, AMD is a multifactorial
complex condition with molecular mechanism that remains unre-
vealed. It is connected with numerous intrinsic and extrinsic stress fac-
tors such as multiple genetic polymorphisms [8,9], smoking [10],
dietary habits [11], chronic diseases [12], and harmful solar irradiation
[13]. Importantly, there is a growing body of evidence that cumulative
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possibly lead to AMD irrespective of age. [14–17] The combined result
of this interaction between stress factors are chronic inﬂammatory pro-
cesses and oxidative stress, that ultimately lead to retinal DNA and pro-
tein damage and degradation of sensitive photoreceptor cells.
In this study, we sought to investigate retinal proteome changes in
UV-irradiated rats (Wistar albino rats) displaying retinal pathology sim-
ilar to that found in AMD in humans. The animals were divided in three
groups based on the treatment conditions, namely UVA, UVB and con-
trol groups. By using state-of-the-art mass spectrometric technology,
we developed a new strategy for reliable and accurate determination
of global qualitative and quantitative differences in retinal proteome
resulting from different types of UV irradiation. Such experimental ap-
proach resulted in the identiﬁcation of several novel protein biomarkers
of UV phototoxicity and disclosed speciﬁcmolecular processes thatmay
advance current knowledge of AMD pathogenesis in humans.
2. Materials
2.1. In vivo model of age related macular degeneration
For in vivo model of disease pathogenesis and its biological
processes, Wistar albino rat was chosen. We used the total number of
24 three-month old male rats from The Institute for Medical Research
in Zagreb, Croatia. The animals were fed with a commercial rodent
chow (Mucedola, Italy) and drinking water ad libitum. They were kept
in appropriate cages and under ambient light by the time of irradiation
of the retina. The experimentwas approved by the Bioethics Committee
of Ruđer Bošković Institute in Zagreb, Croatia.
2.2. Experimental procedure for UV light-induced age related macular
degeneration
Light intensity, including the light reaching the actual cages, was set
at values (30 lx) which do not affect the rats' behavior related to living
space usage and/or sleeping patterns. A uniform light level between
the cages is provided in a way that no cages are on top of the cage
rack directly exposed to light, and all the racks are at the same distance
relative to the light source. The light/dark cycle (0.1–0.01 lx) was set on
a 12/12 cycle throughout the experiment (light on from 7 AM to 7 PM).
Dimmers were used to enable creation of twilight period for 30 min
twice a day. Experimental procedures were always performed at the
same time (9:00 AM). Before the eye (retina) irradiation process rats
were anesthetized by intraperitoneal injection of Nembutal 0.1 ml/
100 g and 0.1 ml/100 g Ketoprofen (Pliva, Croatia). Then the animals
were laid eyes open on the ground. In front of them was a UV lamp
3UV-38 (Cole-Palmer International, USA) at the prescribed distance of
15 cm (according to the manufacturer's instructions). In order to accu-
rately measure the dose of irradiation the radiation detector for proper
UV regionwas set in a plane parallel with animal heads. Irradiation time
was 10 min.
The animals were grouped into three categories:
• Group A: 8 male rats irradiated with the UVA rays of a wavelength
λ= 365 nm. The radiation dose was 500 mJ/cm2,
• Group B: 8 male rats irradiated with UVB rays of a wavelength λ=
302 nm. The radiation dose was 35 mJ/cm2,
• Control group C: 8 male rats that were not irradiated and served as
control animals.
After irradiation the fundus of the rat eye was recorded with so
called fundus camera (Kowa, Japan). In rats irradiated with UVA and
UVB rays pathological changes that include the classic symptoms of ret-
inal degeneration as neovascularization, depigmentation and accumula-
tion of drusen were observed. In the control animals the changes in thestructure of the retina were not determined. Then, the rats were eutha-
nized and retinaswere retrieved and stored immediately in liquid nitro-
gen at−185 °C until further analysis.
3. Methods
3.1. Preparation of retinal tissue homogenates
Rat retinasweremechanically grinded and homogenized in amortar
with liquid nitrogen.Homogenized tissuewasdissolved in 1ml of a lysis
buffer [7 M urea/2 M thiourea (Sigma-Aldrich, USA), 4% (w/v) CHAPS
(Sigma-Aldrich), 0.2% (w/v) mixture of ampholytes pH 3–10 (Bio-Rad,
USA), 1% (w/v) dithiothreitol (DTT) (Sigma-Aldrich)] and 1× protease
inhibitor cocktail (Roche, Switzerland). The obtained lysate was sub-
jected to sonication with 4 mm probe, power of 6 W (Microson™, PGC
Scientiﬁcs, USA), four times for 10 s. After sonication 10 μl of nuclease
mix (Amersham, USA) was added to the samples and incubated for
1 h at room temperature with gentle agitation on a thermoshaker
(Eppendorf, Germany). After that the samples were centrifuged for
45 min at 14 000 rpm and 4 °C (Eppendorf, Germany). The supernatant
was collected and stored at−80 °C. Protein concentrations were deter-
mined using the Qubit™ ﬂuorometric (Invitrogen, USA) quantitation
platform. Before measurement of protein concentration the platform
was calibrated with Qubit protein standards (Invitrogen, USA). All fur-
ther experimental procedures were performed on individual retina
samples.
3.2. Preparation of samples for mass spectrometry analysis
For mass spectrometry analysis (LTQ Orbitrap Velos Thermo Fisher
Scientiﬁc, Bremen, Germany) six samples from each group were pre-
pared using a commercial kit for protein digestion RapiGestSF (Waters,
USA) according to themanufacturer's instructions. Brieﬂy 250 μg of total
protein were precipitated in four volumes of ice cold acetone at−20 °C
overnight for removal of ionic impurities and lipids. After the precipita-
tion of proteins the samples were centrifuged for 10 min at 4 °C and 14
000 rpm followed by acetone removal and drying out the protein pre-
cipitates in a vacuumconcentrator (Eppendorf, Germany). To each sam-
ple 50 μl 0.1% working RapiGestSF solution and DTT 5 mM (Sigma-
Aldrich) were added. After incubation of 30 min at 50 °C, the sample
was cooled to room temperature, and iodoacetamide at ﬁnal concentra-
tion 15 mMwas added in a dark chamber for 30 min. Enzymatic diges-
tion of proteins was performed by addition of 5 μl of sequencing grade
trypsin at ﬁnal trypsin concentration of 20 μg/ml (Promega, Madison,
WI, USA) to each sample and incubation for 4 h at 37 °C. RapiGest SF sur-
factant (Waters, UK) was hydrolyzed by adding TFA (Sigma-Aldrich) to
a ﬁnal concentration of 0.5% and incubation at 37 °C for 35 min. Acid
treated samples were then centrifuged for 10 min at 15 °C and
14000 rpm and the solutions were transferred to new vials. Aliquots
containing approximately 6 μg protein (2.5% of the original amount)
were desalted by using ZipTip C18 pipette tips (Merck Millipore,
Billerica, MA, USA) essentially according to the protocol of themanufac-
turer. Peptides were eluted with 10 μl of a solution containing 60%
acetonitrile (Sigma-Aldrich) and 0.1% TFA and dried in a vacuum con-
centrator (Eppendorf, Germany). The samples were redissolved in
20 μl of 3% acetonitrile and 0.1% formic acid for the LC/MS analyses.
3.3. Mass spectrometry analysis
Sampleswere analyzed on an LTQOrbitrap Velosmass spectrometer
(Thermo Fisher Scientiﬁc, Bremen, Germany) coupled to an Easy-nLC
1000 HPLC system (Thermo Fisher Scientiﬁc). Solvent composition of
buffer A was 0.1% formic acid in water, and buffer B contained 0.1%
formic acid in acetonitrile. 6 μl of the peptide samples were loaded
onto a frit column (75 μm inner diameter) packed with a reverse
phase C18 material (AQ, 3 μm 200 Å, Bischoff GmbH, Leonberg,
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LC gradient was applied: 0 min: 0% buffer B, 110 min: 30% B, 120 min:
50% B, 122 min: 100% B, and 130 min: 100% B.
Survey scans were recorded in the Orbitrap mass analyzer in the
range of m/z 300–2000 with a resolution of 30000 at m/z 400. MS/MS
spectra were acquired from the 20most intense signals above a thresh-
old of 1000 counts in the ion trap. A normalized collision energy of 35%
and an activation time of 10 ms were used and the precursor ion isola-
tion width was m/z 2.0. Charge state screening was enabled and singly
charged ions and unassigned charge states were rejected. Precursor
masses already selected for MS/MS acquisition were excluded for fur-
ther selection during 45 s and the exclusion windowwas set to 20 ppm.
3.4. Protein identiﬁcation and protein quantiﬁcation
The raw ﬁles from the mass spectrometer were loaded into
Progenesis LCMS (v.4.0.4265.42984) (Supplementary material). Before
the automatic aligning the loading and the wash phase of the gradient
were cut, the aligning reference was chosen based on the highest num-
ber of visible features. From each Progenesis feature (default sensitivity
in peak picking) a maximum of the top ﬁve tandemmass spectra were
exported using the charge deconvolution and deisotoping option and a
maximum number of 200 peaks per MS/MS. The Mascot generic ﬁle
(.mgf) was searched with Mascot Server v.2.4.1 (www.matrixscience.
com) using the parameters 10 ppm for precursor ion mass tolerance,
0.6 Da for fragment ion tolerance. Trypsin was used as the protein-
cleaving enzyme, twomissed cleavageswere allowed. Carbamidometh-
ylation of cysteine was speciﬁed as a ﬁxed modiﬁcation, and oxidation
of methionine, pyroglutamate formation from N-terminal glutamine,
deamidation from glutamine and asparagine and N-terminal acetyla-
tion of proteins were selected as variable modiﬁcations.
Mass spectrometry data were searched against a forward and re-
versed rat database (downloaded on 18/04/2013 from UniProt)
concatenated to 260 known mass spectrometry contaminants in order
to evaluate the false discovery rate using the target–decoy strategy
[18]. The mascot result was loaded into Scaffold v4.1.1 using 95%
PeptideProphet and ProteinProphet thresholds and protein cluster anal-
ysis. The spectrum report was exported and loaded into ProgenesisLCMS
(Supplementary material).
In the experimental designwe used a between group analysis where
two relevant experimental designs were generated. A) Control group
(n = xx) and UV A (n = xx). B) Control group (n = xx) and UV B
(n = xx). Normalization was performed by using the default settings.
For quantiﬁcation we assessed all proteins identiﬁed with at least 2
features. Proteins were grouped with Progenesis and only non-
conﬂicting features were used for quantiﬁcation. Depending on the ex-
perimental design we tagged proteins which exceeded a 2-fold change
and which showed a p-value smaller than 0.05 as being relevant and
differentially expressed in the respective experimental design. Present-
ed results represent data obtained from individually analysed samples.
3.5. Western blot analysis
For the Western blot procedure a total amount of 50 μg of retinal
proteins were resolved on 12% SDS polyacrylamide gels using the
Mini-protean cell (Bio-Rad, USA). The PVDF (Bio-Rad, USA)membranes
were incubated with primary antibodies raised against lumican
(1:1000, rabbit mAb, Abcam, UK) and galectin 5 (R-19) (1:300, goat
pAb, Santa Cruz, CA) at 4 °C overnight. Secondary antibody linked to
anti-rabbit (1:1000, Dako, USA) and to anti-goat (1:1000, Abcam, UK)
respectively, was used. The signal was visualized byWestern Lightening
Chemiluminescence Reagent Plus Kit (PerkinElmer, USA) on the
ImageQuant LAS 500 (GE Healthcare, USA) and α-tubulin (1:1000,
mouse mAb, Sigma, USA) was used as a loading control. The signal in-
tensities of particular bands were normalized with the intensity of the
loading control and compared in Quantity One software (Bio-Rad,USA). The values are expressed as the average ± standard deviation.
Statistical analysis was performed in Microsoft Excel by using the
ANOVA at p b 0.05.
4. Results
Mass spectrometric analysis (for a detailed view of mass spectrome-
try data please see Supplementarymaterial) identiﬁed a total number of
85 retinal proteins that were differentially expressed between control
rats and those exposed to UV treatment. In particular, UVA irradiation
induced the expression of 14 proteins with concomitant decrease in
the expression levels of 39 proteins (Table 1) (for a detailed view of
mass spectrometry data please see Supplementarymaterial). More pro-
found effectswere observed inUVB irradiated retinaswhere 28 and 467
proteins were increased or decreased, respectively, in exposed retinas
(Table 2). Interestingly, an overlap in retinal proteomes between UVA
and UVB could be observed as 45 proteins were found in common for
both types of irradiation.
In order to assign biological functions and determine their subcellu-
lar localization, identiﬁed proteins (Tables 1 and 2) were further sub-
jected to UniProt (http://beta.uniprot.org/) and Gene Ontology (http://
amigo.geneontology.org/amigo) database searches. This analysis re-
vealed that 40% of the total proteins were cytoplasmic, 21% belonged
to various organelles being predominantly nuclear proteins (80%), 14%
to secreted proteins and 11% to membrane proteins (Table 3). In addi-
tion, 6% of proteins constituted intermediate ﬁlaments, and 5% were
part of the hemoglobin complex. Identiﬁed proteins play essential
roles in a wide variety of biological processes and functions including
oxygen transport, cellular metabolism, cell differentiation, nucleosome
assembly, regulation of transcription, DNA binding, collagen ﬁbril orga-
nization, cell adhesion, ion transport,muscle contraction, cell aging, reg-
ulation and maintenance of cytoskeleton structure, iron metabolism,
regulation of structure and functioning of interphotoreceptormatrix, in-
ﬂammation and immune response, epigenetic regulation, metabolic
and oxidative stress, apoptosis, retinal vascular permeability, molecular
motors, phototransduction, DNA damage and repair and protein
binding.
Mass spectrometry analysis speciﬁcally revealed up-regulation of
galectin-5, whose expression was increased in both UVA and UVB ex-
posed retinas in comparison with control, which was additionally cor-
roborated by Western blot analysis (Fig. 1). However, a statistically
signiﬁcant rise in galectin-5 level was only detected in UVB treated ret-
ina. Galectins are carbohydrate-binding proteins that regulate different
biological processes including cell–cell and cell–matrix interactions.
Their role in adhesion and migration of retinal pigment epithelial cells
was previously recognized in the pathogenesis of proliferative
vitreoretinopathy [19,20]. Importantly, some galectins in corneal epi-
thelium including galectin-3 are capable of binding extracellular matrix
molecules contained within the corneal epithelial basement membrane
such as laminin-5, netrin and lumican. The expression of the latter was
signiﬁcantly reduced in UVB treated retina; however, a trend towards
decline in its expression level could be observed in UVA treated retina
as well (Fig. 1). Apart from lumican, many other extracellular matrix
proteins belonging to the small leucine-rich proteoglycan (SLRP) family
of proteins were commonly down-regulated upon both types of
irradiation including ﬁbromodulin, decorin, osteoglycin, biglycan and
keratocan. Western blot analysis conﬁrmed a complete loss of biglycan
expression in both types of UV irradiation (Fig. 1). These results suggest
that UV-induced retinal damage can be associated with structural
changes and reassembly of the ECM components and their cell surface
receptors.
Src family kinases control a variety of biological processes ranging
from cell adhesion, migration, proliferation, and survival (Inhibition of
Src family kinases with dasatinib blocks migration and invasion of
humanmelanoma cells.). Src activity is regulated by tyrosine phosphor-
ylation at two sites, but with opposing effects. Phosphorylation of
Table 1
List of differentially regulated proteins in control vs. UVA group with given individual expression status and biological processes.
Accession no. PC PQ Anova
(p)
Log2
(control
vs. UVA)
Expression
status
Maximum
fold
change
Description Biological process
F8WFT7_RAT 9 9 0.0014 3.31 ↑In UVA 9.9 Band 3 anion transport protein OS = Rattus
norvegicus GN= Slc4a1 PE = 4 SV = 1
[F8WFT7_RAT,sp|P23562-2|B3AT_RAT,sp|
P23562|B3AT_RAT]
Inorganic anion exchanger
activity
Q62669_RAT 24 11 0.0005 2.92 ↑In UVA 7.5 Protein Hbb-b1 OS = Rattus norvegicus
GN =MGC72973 PE = 3 SV = 1
Oxygen transport
HBB1_RAT 42 9 0.0003 2.81 ↑In UVA 7.0 Hemoglobin subunit beta-1 OS = Rattus
norvegicus GN= Hbb PE = 1 SV = 3
Oxygen transport
HBA_RAT 18 16 0.0003 2.78 ↑In UVA 6.8 Hemoglobin subunit alpha-1/2 OS = Rattus
norvegicus GN= Hba1 PE = 1 SV = 3
Oxygen transport
CAH1_RAT 14 14 0.0009 2.67 ↑In UVA 6.4 Carbonic anhydrase 1 OS = Rattus norvegicus
GN = Ca1 PE = 1 SV = 1
One-carbon metabolic
process
HBB2_RAT 37 4 0.0004 2.42 ↑In UVA 5.3 Hemoglobin subunit beta-2 OS = Rattus
norvegicus PE = 1 SV = 2
Oxygen transport
LEG5_RAT 4 4 0.0014 2.17 ↑In UVA 4.5 Galectin-5 OS = Rattus norvegicus
GN = Lgals5 PE = 1 SV = 2
Carbohydrate binding
CRGD_RAT 39 5 0.0003 2.16 ↑In UVA 4.5 Gamma-crystallin D OS = Rattus norvegicus
GN = Crygd PE = 2 SV = 2
Lens ﬁber cell differentiation
Q63910_RAT 8 6 0.0057 1.51 ↑In UVA 2.8 Alpha globin OS = Rattus norvegicus
GN = LOC287167 PE = 3 SV = 2
Oxygen transport
G3V6H9_RAT 3 3 0.0455 1.46 ↑In UVA 2.8 Nucleosome assembly protein 1-like 1 OS =
Rattus norvegicus GN= Nap1l1 PE = 3 SV = 1
Nucleosome assembly
ALBU_RAT 57 1 0.0297 1.42 ↑In UVA 2.7 Serum albumin OS = Rattus norvegicus
GN = Alb PE = 1 SV = 2
Transport
O88752_RAT 4 2 0.0440 1.29 ↑In UVA 2.4 Epsilon 1 globin OS = Rattus norvegicus
GN = Hbe1 PE = 2 SV = 1
Oxygen transport
APOA1_RAT 2 2 0.0036 1.25 ↑In UVA 2.4 Apolipoprotein A-I OS = Rattus norvegicus
GN = Apoa1 PE = 1 SV = 2
Cholesterol metabolism, lipid
metabolism, lipid transport,
steroid metabolism, sterol
metabolism, transport
CAH2_RAT 13 13 0.01609 1.09 ↑In UVA 2.1 Carbonic anhydrase 2 OS = Rattus norvegicus
GN = Ca2 PE = 1 SV = 2
Regulation of cellular pH,
regulation of anion
transport, cellular response
to ﬂuid shear stress
F8WG17_RAT 2 2 0.0030 −3.04 ↑In
control
8.2 Troponin I, fast skeletal muscle (Fragment)
OS = Rattus norvegicus GN = Tnni2 PE = 4
SV = 2 [F8WG17_RAT,TNNI2_RAT]
Positive regulation of
transcription
D3ZIU9_RAT 2 2 0.01472 −2.45 ↑In
control
5.5 Protein RGD1560584 OS = Rattus norvegicus
GN = RGD1560584 PE = 4 SV = 2
[D3ZIU9_RAT,D3ZXR5_RAT]
DNA binding
FMOD_RAT 8 8 0.0011 −2.33 ↑In
control
5.0 Fibromodulin OS = Rattus norvegicus
GN = Fmod PE = 2 SV = 1
[FMOD_RAT,G3V6E7_RAT]
Wound healing
ACON_RAT 3 3 0.0027 −2.21 ↑In
control
4.6 Aconitate hydratase, mitochondrial
OS = Rattus norvegicus GN = Aco2
PE = 1 SV = 2
Tricarboxylic acid cycle
Q8SEZ5_RAT 2 2 0.0012 −2.16 ↑In
control
4.5 Cytochrome c oxidase subunit 2 OS =
Rattus norvegicus GN=Mt-co2 PE = 3 SV = 1
Cytochrome-c oxidase
activity
F1LQC3_RAT 25 14 0.0009 −2.09 ↑In
control
4.3 Collagen alpha-1(XII) chain (Fragment)
OS = Rattus norvegicus GN = Col12a1
PE = 2 SV = 2
Collagen ﬁbril organization
D3Z9F8_RAT 24 13 0.0009 −2.08 ↑In
control
4.3 Collagen alpha-1(XII) chain OS = Rattus
norvegicus GN= Col12a1 PE = 2 SV = 2
Collagen ﬁbril organization,
cell adhesion
D3ZXP3_RAT;D4ACV3_RAT;G3V9C0_RAT;
H2A1_RAT;H2A1C_RAT;H2A1E_RAT;
H2A1F_RAT;H2A2A_RAT;H2A3_RAT;
H2A4_RAT;H2AJ_RAT;M0RCL5_RAT;
M0RDM4_RAT;Q6I8Q6_RAT
4 3 0.0190 −2.05 ↑In
control
1.6 Histone H2A OS = Rattus norvegicus
GN = H2afx PE = 3 SV = 1
Nucleosome assembly
AATC_RAT 3 3 0.0198 −2.01 ↑In
control
4.0 Aspartate aminotransferase, cytoplasmic
OS = Rattus norvegicus GN = Got1
PE = 1 SV = 3
Amino-acid biosynthesis
VAT1_RAT 2 2 0.0031 −1.98 ↑In
control
3.9 Synaptic vesicle membrane protein
VAT-1 homologue OS = Rattus norvegicus
GN = Vat1 PE = 1 SV = 1
Epidermal repair
mechanisms
M0R6J6_RAT 2 2 0.0415 −1.86 ↑In
control
3.6 Uncharacterized protein OS = Rattus
norvegicus PE = 4 SV = 1
Kinase activity
PGS2_RAT 9 9 0.0105 −1.78 ↑In
control
3.4 Decorin OS = Rattus norvegicus GN = Dcn
PE = 1 SV = 1
Aging, wound healing
MYL6_RAT 3 2 0.0034 −1.7 ↑In
control
3.2 Myosin light polypeptide 6 OS = Rattus
norvegicus GN=Myl6 PE = 1 SV = 3
ATP catabolic process,
skeletal muscle tissue
development
Contaminant 3 1 0.0258 −1.66 ↑In
control
/ gi|2497269|sp|Q99456| K1CL_HUMAN
KERATIN, TYPE I CYTOSKELETAL 12
/
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Table 1 (continued)
Accession no. PC PQ Anova
(p)
Log2
(control
vs. UVA)
Expression
status
Maximum
fold
change
Description Biological process
AT2A1_RAT 12 12 0.0137 −1.58 ↑In
control
3.0 Sarcoplasmic/endoplasmic reticulum
calcium ATPase 1 OS = Rattus norvegicus
GN = Atp2a1 PE = 2 SV = 1
Calcium transport, ion
transport,
F1LMU0_RAT 54 13 0.0143 −1.56 ↑In
control
2.9 Myosin-4 OS = Rattus norvegicus GN =
Myh4 PE = 2 SV = 1
Muscle contraction
F1LRV9_RAT 47 3 0.0156 −1.52 ↑In
control
2.9 Protein Myh1 OS = Rattus norvegicus
GN =Myh1 PE = 2 SV = 2
Metabolic process
D4A111_RAT 87 87 0.0006 −1.52 ↑In
control
2.9 Protein Col6a3 OS = Rattus norvegicus
GN = Col6a3 PE = 4 SV = 2
Response to glucose
TPM2_RAT 5 2 0.0372 −1.51 ↑In
control
2.8 Tropomyosin beta chain OS = Rattus
norvegicus GN= Tpm2 PE = 2 SV = 1
Regulation of ATPase activity
KCRM_RAT 6 6 0.0291 −1.5 ↑In
control
2.8 Creatine kinase M-type OS = Rattus
norvegicus GN= Ckm PE = 1 SV = 2
Phosphocreatine
biosynthetic process
D3ZVD7_RAT 8 8 0.0035 −1.44 ↑In
control
2.7 Keratocan (predicted) OS = Rattus
norvegicus GN= Kera PE = 4 SV = 1
Cornea development in
camera-type eye
MYL1_RAT 12 11 0.0097 −1.43 ↑In
control
2.7 Myosin light chain 1/3, skeletal muscle
isoform OS = Rattus norvegicus
GN =Myl1 PE = 1 SV = 2
Muscle ﬁlament sliding
F1LNH3_RAT 14 14 0.0015 −1.35 ↑In
control
2.5 Procollagen, type VI, alpha 2, isoform
CRA_a OS = Rattus norvegicus
GN = Col6a2 PE = 2 SV = 2
Protein heterotrimerization
HNRPK_RAT 2 2 0.0098 −1.33 ↑In
control
2.5 Heterogeneous nuclear ribonucleoprotein
K OS = Rattus norvegicus GN = Hnrnpk
PE = 1 SV = 1 [HNRPK_RAT,Q5D059_RAT]
Regulation of intrinsic
apoptotic signaling pathway
in response to DNA damage
by p53 class mediator
TPM1_RAT 6 3 0.0324 −1.25 ↑In
control
2.4 Isoform 6 of Tropomyosin alpha-1 chain
OS = Rattus norvegicus GN = Tpm1
[sp|P04692-3|TPM1_RAT,sp|P04692-
6|TPM1_RAT,sp|P04692|TPM1_RAT]
Actin ﬁlament capping,
wound healing
K6PL_RAT 2 2 0.0489 −1.25 ↑In
control
2.4 6-phosphofructokinase, liver type
OS = Rattus norvegicus GN = Pfkl
PE = 2 SV = 3
Carbohydrate metabolic
process
D3ZVB7_RAT 5 5 0.0338 −1.25 ↑In
control
2.4 Osteoglycin (predicted) OS = Rattus
norvegicus GN= Ogn PE = 4 SV = 1
Negative regulation of
smooth muscle cell
proliferation
MLRS_RAT 10 10 0.0376 −1.25 ↑In
control
2.4 Myosin regulatory light chain 2, skeletal
muscle isoform OS = Rattus norvegicus
GN =Mylpf PE = 2 SV = 2
Immune response, skeletal
muscle tissue development
D4A931_RAT 18 16 0.0030 −1.23 ↑In
control
2.3 Keratin, type I cytoskeletal 12 OS = Rattus
norvegicus GN= Krt12 PE = 2 SV = 2
Visual perception
ADT2_RAT;Q6P9Y4_RAT 3 1 0.0468 −1.21 ↑in
control
2.3 ADP/ATP translocase 2 OS = Rattus
norvegicus GN= Slc25a5 PE = 1 SV = 3
Negative regulation of
mitochondrial outer
membrane permeabilization
involved in apoptotic
signaling pathway
TPM4_RAT 3 1 0.01519 −1.21 ↑In
control
2.3 Tropomyosin alpha-4 chain OS = Rattus
norvegicus GN= Tpm4 PE = 1 SV = 3
Muscle contraction
ENOB_RAT 10 2 0.0003 −1.18 ↑In
control
2.3 Beta-enolase OS = Rattus norvegicus
GN = Eno3 PE = 1 SV = 3
Aging, skeletal muscle tissue
regeneration
HS90B_RAT 6 3 0.0051 −1.17 ↑In
control
2.2 Heat shock protein HSP 90-beta OS = Rattus
norvegicus GN= Hsp90ab1 PE = 1 SV = 4
Response to unfolded
protein
D3ZAY2_RAT 2 2 0.0335 −1.14 ↑In
control
2.2 Protein Epb4.1 l2 OS = Rattus norvegicus
GN = Epb4.1 l2 PE = 2 SV = 2
[D3ZAY2_RAT,D3ZAY7_RAT,
D3ZDT1_RAT,D3ZM69_RAT]
Cytoskeletal protein binding
AL3A1_RAT 19 19 0.0040 −1.13 ↑In
control
2.2 Aldehyde dehydrogenase, dimeric
NADP-preferring OS = Rattus norvegicus
GN = Aldh3a1 PE = 1 SV = 3
Aging, oxidation-reduction
process
PRELP_RAT 10 10 0.0115 −1.13 ↑In
control
2.2 Prolargin OS = Rattus norvegicus
GN = Prelp PE = 2 SV = 1
Cell aging
D3ZUL3_RAT 19 19 0.0138 −1.06 ↑In
control
2.1 Protein Col6a1 OS = Rattus norvegicus
GN = Col6a1 PE = 4 SV = 1
Cellular response to amino
acid stimulus, protein
heterotrimerization
ATPB_RAT 12 12 0.0186 −1.06 ↑In
control
2.1 ATP synthase subunit beta, mitochondrial
OS = Rattus norvegicus GN = Atp5b
PE = 1 SV = 2 [ATPB_RAT,G3V6D3_RAT]
ATP synthesis, hydrogen ion
transport, ion transport,
1433T_RAT 5 1 0.0221 −1.05 ↑In
control
2.1 14-3-3 protein theta OS = Rattus
norvegicus GN= Ywhaq PE = 1 SV = 1
Protein targeting
VDAC1_RAT 5 5 0.0109 −1.01 ↑In
control
2.0 Voltage-dependent anion-selective channel
protein 1 OS = Rattus norvegicus
GN = Vdac1 PE = 1 SV = 4
Apoptosis, ion transport,
transport
Abbreviations: PC—number of identiﬁed peptides; PQ—number of peptides that are used for quantitation; Log2—Log2 UV A group vs Control group.
1837S. Kraljević Pavelić et al. / Biochimica et Biophysica Acta 1852 (2015) 1833–1845
Table 2
List of differentially regulated proteins in control vs. UVB group with given individual expression status and involvement in known biological processes.
Acession no. PC PQ Anova
(p)
Log 2
(control
vs. UVB)
Expression
status
Maximum
fold
change
Description Biological process
LEG5_RAT 4 4 0.0006 4.79 ↑In UVB 27.7 Galectin-5 OS = Rattus norvegicus GN = Lgals5
PE = 1 SV = 2
Carbohydrate binding
Q62669_RAT 24 11 0.0025 4.68 ↑In UVB 25.6 Protein Hbb-b1 OS = Rattus norvegicus
GN =MGC72973 PE = 3 SV = 1
Oxygen transport
F8WFT7_RAT 9 9 0.0071 4.36 ↑In UVB 20.5 Band 3 anion transport protein OS = Rattus
norvegicus GN = Slc4a1 PE = 4 SV = 1
[F8WFT7_RAT,sp|P23562-2|B3AT_RAT,
sp|P23562|B3AT_RAT]
Inorganic anion exchanger
activity
CAH1_RAT 14 14 0.0004 4.29 ↑In UVB 19.5 Carbonic anhydrase 1 OS = Rattus
norvegicus GN = Ca1 PE = 1 SV = 1
One-carbon metabolic
process
APOA1_RAT 2 2 0.0053 4.13 ↑In UVB 17.6 Apolipoprotein A-I OS = Rattus
norvegicus GN = Apoa1 PE = 1 SV = 2
Oxygen transporter activity
HBB1_RAT 42 9 0.0001 4.1 ↑In UVB 17.1 Hemoglobin subunit beta-1 OS = Rattus
norvegicus GN = Hbb PE = 1 SV = 3
Heme catabolic process
B5DF65_RAT 4 4 0.0132 3.98 ↑In UVB 15.8 Biliverdin reductase B (ﬂavin reductase (NADPH))
OS = Rattus norvegicus GN = Blvrb PE = 2 SV = 1
Oxygen transport
HBA_RAT 18 16 0.0001 3.9 ↑In UVB 15.0 Hemoglobin subunit alpha-1/2 OS = Rattus
norvegicus GN = Hba1 PE = 1 SV = 3
Oxygen transport
HBB2_RAT 37 4 0.0001 3.77 ↑In UVB 13.6 Hemoglobin subunit beta-2 OS = Rattus
norvegicus PE = 1 SV = 2
Oxygen transport
A1M_RAT 19 19 0.0063 3.62 ↑In UVB 12.3 Alpha-1-macroglobulin OS = Rattus
norvegicus GN = A1m PE = 1 SV = 1
Serine-type endopeptidase
inhibitor activity
O88752_RAT 4 2 0.0089 3.55 ↑In UVB 11.7 Epsilon 1 globin OS = Rattus norvegicus
GN = Hbe1 PE = 2 SV = 1
Oxygen transport
FIBG_RAT 3 3 0.0022 3.14 ↑In UVB 8.8 Isoform Gamma-A of ﬁbrinogen gamma
chain OS = Rattus norvegicus GN = Fgg
[sp|P02680-2|FIBG_RAT,sp|P02680|FIBG_RAT]
Inﬂammatory response
Q63910_RAT 8 6 0.0007 2.66 ↑In UVB 6.3 Alpha globin OS = Rattus norvegicus
GN = LOC287167 PE = 3 SV = 2
Oxygen transporter activity
CATA_RAT 7 7 0.0428 2.64 ↑in UVB 6.2 Catalase OS = Rattus norvegicus
GN = Cat PE = 1 SV = 3
response to oxidative stress
Contaminant 3 2 0.0176 2.4 ↑In UVB / sp|ALBU_BOVIN| [zz|ZZ_FGCZCont0112|,
zz|ZZ_FGCZCont0218|]
/
CAH2_RAT 13 13 0.0024 2.27 ↑In UVB 4.8 Carbonic anhydrase 2 OS = Rattus
norvegicus GN = Ca2 PE = 1 SV = 2
Regulation of cellular pH and
anion transport
GBB1_RAT 5 5 0.0079 2.19 ↑In UVB 4.6 Guanine nucleotide-binding protein
G(I)/G(S)/G(T) subunit beta-1 OS = Rattus
norvegicus GN = Gnb1 PE = 1 SV = 4
Apoptotic process
WDR1_RAT 4 4 0.0011 1.95 ↑In UVB 3.9 WD repeat-containing protein 1 OS = Rattus
norvegicus GN =Wdr1 PE = 1 SV = 3
Disassembly of actin
ﬁlaments
D3ZZ79_RAT 2 2 0.0008 1.9 ↑In UVB 3.7 Protein Spem1 OS = Rattus norvegicus
GN = Spem1 PE = 4 SV = 1
Unknown
ALBU_RAT 57 1 0.0246 1.78 ↑In UVB 3.4 Serum albumin OS = Rattus norvegicus
GN = Alb PE = 1 SV = 2
Transport
PRDX2_RAT 7 7 0.0159 1.74 ↑In UVB 3.3 Peroxiredoxin-2 OS = Rattus norvegicus
GN = Prdx2 PE = 1 SV = 3
Response to oxidative stress,
removal of superoxide
radicals
Contaminant 7 7 0.0284 1.65 ↑In UVB Trypa5|PromTArt5 Promega trypsin artifact
5 K to R mods (2239.1, 2914)
/
G3V6H9_RAT 3 3 0.0170 1.6 ↑In UVB 3.0 Nucleosome assembly protein 1-like 1
OS = Rattus norvegicus GN = Nap1l1
PE = 3 SV = 1
Nucleosome assembly
CRGD_RAT 39 5 0.0380 1.58 ↑In UVB 3.0 Gamma-crystallin D OS = Rattus
norvegicus GN = Crygd PE = 2 SV = 2
Lens ﬁber cell differentiation
GSTM1_RAT 7 6 0.0043 1.57 ↑In UVB 3.0 Glutathione S-transferase Mu 1 OS = Rattus
norvegicus GN = Gstm1 PE = 1 SV = 2
Response to axon injury,
glutathione metabolic
process
Contaminant 7 1 0.0316 1.57 ↑In UVB / gi|71536|pir|| KRHU2 keratin, 67 K type II
cytoskeletal – human (fragment)
/
Contaminant 6 6 0.0130 1.46 ↑In UVB / sp|TRYP_PIG| /
D4AC23_RAT 2 2 0.0002 1.24 ↑In UVB 2.4 Protein Cct7 OS = Rattus norvegicus
GN = Cct7 PE = 3 SV = 1
binding of sperm to zona
pellucida
TERA_RAT 3 3 0.0073 1.23 ↑In UVB 2.3 Transitional endoplasmic reticulum ATPase OS =
Rattus norvegicus GN = Vcp PE = 1 SV = 3
Cellular response to DNA
damage stimulus,
double-strand break repair
SODC_RAT 3 3 0.0175 1.12 ↑In UVB 2.2 Superoxide dismutase [Cu–Zn] OS = Rattus
norvegicus GN = Sod1 PE = 1 SV = 2
Positive regulation of
intrinsic apoptotic signaling
pathway in response to
oxidative stress, reactive
oxygen species metabolic
process, retina homeostasis
NDRG1_RAT 9 9 0.0295 1.06 ↑In UVB 2.1 Protein NDRG1 OS = Rattus norvegicus GN= Ndrg1
PE = 1 SV = 1
DNA damage response
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Table 2 (continued)
Acession no. PC PQ Anova
(p)
Log 2
(control
vs. UVB)
Expression
status
Maximum
fold
change
Description Biological process
KPYM_RAT 28 4 0.0040 1 ↑In UVB 2.0 Isoform M2 of pyruvate kinase isozymes
M1/M2 OS = Rattus norvegicus GN = Pkm
Organ regeneration
M0R6J6_RAT 2 2 0.0060 −4.5 ↑In control 22.6 Uncharacterized protein OS = Rattus
norvegicus PE = 4 SV = 1
Kinase activity
D3ZIU9_RAT 2 2 0.0040 −4.31 ↑In control 19.8 Protein RGD1560584 OS = Rattus
norvegicus GN = RGD1560584 PE = 4 SV = 2
[D3ZIU9_RAT,D3ZXR5_RAT]
DNA binding
F1LPQ5_RAT 2 2 0.0113 −4.16 ↑In control 17.9 Troponin T, fast skeletal muscle (fragment)
OS = Rattus norvegicus GN= Tnnt3 PE = 2
SV= 2 [F1LPQ5_RAT,sp|P09739-2|TNNT3_RAT,
sp|P09739-3|TNNT3_RAT,sp|P09739-4|TNNT3_RAT,
sp|P09739-5|TNNT3_RAT,sp|P09739-6|TNNT3_RAT,
sp|P09739-7|TNNT3_RAT,sp|P09739|TNNT3_RAT]
ATP catabolic process
FMOD_RAT 8 8 6.1508E−06 −4.1 ↑In control 17.1 Fibromodulin OS = Rattus norvegicus
GN = Fmod PE = 2 SV = 1
[FMOD_RAT,G3V6E7_RAT]
Wound healing
Contaminant 3 1 0.0040 −3.35 ↑In control / gi|2497269|sp|Q99456| K1CL_HUMAN KERATIN,
TYPE I CYTOSKELETAL 12 (CYTO
F1LQC3_RAT 25 14 2.6343E−06 −3.23 ↑In control / Collagen alpha-1(XII) chain (fragment)
OS = Rattus norvegicus GN = Col12a1
PE = 2 SV = 2
Collagen ﬁbril organization
D3Z9F8_RAT 24 13 0.0001 −3.02 ↑In control 9.4 Collagen alpha-1(XII) chain OS = Rattus
norvegicus GN = Col12a1 PE = 2 SV = 2
Collagen ﬁbril organization,
cell adhesion
F8WG17_RAT 2 2 0.0045 −2.98 ↑In control 7.9 Troponin I, fast skeletal muscle (fragment)
OS = Rattus norvegicus GN = Tnni2 PE = 4
SV = 2 [F8WG17_RAT,TNNI2_RAT]
ATP catabolic process
D3ZVK7_RAT 3 2 0.0033 −2.89 ↑In control 7.4 Histone H2A OS = Rattus norvegicus
GN = Hist2h2ac PE = 3 SV = 1
[D3ZVK7_RAT,D4ACV3_RAT,G3V9C0_RAT,
H2A1C_RAT,H2A1E_RAT,H2A1F_RAT,H2A1_RAT,
H2A2A_RAT,H2A3_RAT,H2A4_RAT,H2AJ_RAT,
M0RCL5_RAT,M0RDM4_RAT,Q6I8Q6_RAT]
Nucleosome assembly
D4A931_RAT 18 16 3.8326E−06 −2.88 ↑In control 7.4 Keratin, type I cytoskeletal 12 OS = Rattus
norvegicus GN = Krt12 PE = 2 SV = 2
Visual perception
K2C6A_RAT 7 5 0.0001 −2.84 ↑in control 7.2 Keratin, type II cytoskeletal 6A OS = Rattus
norvegicus GN = Krt6a PE = 1 SV = 1
Cell differentiation
D3ZVB7_RAT 5 5 0.0001 −2.82 ↑In control 7.1 Osteoglycin (predicted) OS = Rattus
norvegicus GN = Ogn PE = 4 SV = 1
Negative regulation of
smooth muscle cell
proliferation
D4A111_RAT 87 87 1.0788E−08 −2.69 ↑In control 6.4 Protein Col6a3 OS = Rattus norvegicus
GN = Col6a3 PE = 4 SV = 2
Response to glucose
1433T_RAT 5 1 0.0002 −2.64 ↑In control 6.3 14-3-3 protein theta OS = Rattus
norvegicus GN = Ywhaq PE = 1 SV = 1
Protein binding
D3ZVD7_RAT 8 8 2.8052E−05 −2.63 ↑In control 6.2 Keratocan (predicted) OS = Rattus
norvegicus GN = Kera PE = 4 SV = 1
Cornea development in
camera-type eye
CO1A1_RAT 9 9 0.0080 −2.46 ↑In control 5.5 Collagen alpha-1(I) chain OS = Rattus
norvegicus GN = Col1a1 PE = 1 SV = 5
Blood vessel development,
response to hydrogen
peroxide
F1LMU0_RAT 54 13 0.0004 −2.45 ↑In control 5.5 Myosin-4 OS = Rattus norvegicus
GN =Myh4 PE = 2 SV = 1
Actin ﬁlament-based
movement
KCRM_RAT 6 6 0.0012 −2.43 ↑In control 5.4 Creatine kinase M-type OS = Rattus
norvegicus GN = Ckm PE = 1 SV = 2
Phosphocreatine
biosynthetic process
AL3A1_RAT 19 19 1.3146E−06 −2.4 ↑In control 5.3 Aldehyde dehydrogenase, dimeric NADP-
preferring OS = Rattus norvegicus
GN = Aldh3a1 PE = 1 SV = 3
Oxidation-reduction process,
aging
VAT1_RAT 2 2 0.0012 −2.33 ↑In control 5.0 Synaptic vesicle membrane protein
VAT-1 homologue OS = Rattus norvegicus
GN = Vat1 PE = 1 SV = 1
Epidermal repair
mechanisms
MYL1_RAT 12 11 0.0012 −2.33 ↑In control 5.0 Myosin light chain 1/3, skeletal muscle isoform
OS = Rattus norvegicus GN =Myl1
PE = 1 SV = 2
Muscle ﬁlament sliding
AT2A1_RAT 12 12 0.0011 −2.31 ↑In control 5.0 Sarcoplasmic/endoplasmic reticulum
calcium ATPase 1 OS = Rattus norvegicus
GN = Atp2a1 PE = 2 SV = 1
ATP catabolic process,
calcium ion transmembrane
transport
K1C15_RAT 10 5 0.0011 −2.21 ↑In control 4.6 Keratin, type I cytoskeletal 15 OS = Rattus
norvegicus GN = Krt15 PE = 1 SV = 1
Response to ionizing
radiation
PGS2_RAT 9 9 0.0031 −2.2 ↑In control 4.6 Decorin OS = Rattus norvegicus GN= Dcn
PE = 1 SV = 1
Aging, wound healing
F1LNH3_RAT 14 14 1.976E−07 −2.19 ↑In control 4.6 Procollagen, type VI, alpha 2, isoform
CRA_a OS = Rattus norvegicus
GN = Col6a2 PE = 2 SV = 2
Protein heterotrimerisation
F1M6T7_RAT 2 2 0.0084 −2.15 ↑In control 4.4 Protein LOC681820 (fragment) OS = Rattus
norvegicus GN = LOC681820 PE = 4 SV = 2
Translational elongation
(continued on next page)
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Table 2 (continued)
Acession no. PC PQ Anova
(p)
Log 2
(control
vs. UVB)
Expression
status
Maximum
fold
change
Description Biological process
TPM2_RAT 5 2 0.0127 −2.13 ↑In control 4.4 Tropomyosin beta chain OS = Rattus
norvegicus GN = Tpm2 PE = 2 SV = 1
Regulation of ATPase activity
K2C5_RAT 28 28 1.241E−06 −2.08 ↑In control 4.2 Keratin, type II cytoskeletal 5 OS = Rattus
norvegicus GN = Krt5 PE = 1 SV = 1
Epidermis development,
collagen ﬁbril organization
D3ZXP3_RAT;D4ACV3_RAT;
G3V9C0_RAT;H2A1_RAT;
H2A1C_RAT;H2A1E_RAT;
H2A1F_RAT;H2A2A_RAT;
H2A3_RAT;H2A4_RAT;
H2AJ_RAT;M0RCL5_RA;
M0RDM4_RAT;Q6I8Q6_RAT
4 3 0.0208 −2.07 ↑In control 7.4 Histone H2A OS = Rattus norvegicus
GN = H2afx PE = 3 SV = 1
Nucleosome assembly
F1LRV9_RAT 47 3 0.0031 −2.02 ↑In control 4.0 Protein Myh1 OS = Rattus norvegicus
GN =Myh1 PE = 2 SV = 2
Metabolic process
LUM_RAT 10 10 4.047
8E−06
−1.97 ↑In control 3.9 Lumican OS = Rattus norvegicus
GN = Lum PE = 2 SV = 1
Rositive regulation of
transcription from RNA
polymerase II promoter
D3ZUL3_RAT 19 19 0.0019 −1.89 ↑In control 3.7 Protein Col6a1 OS = Rattus norvegicus
GN = Col6a1 PE = 4 SV = 1
Cellular response to amino
acid stimulus
CO1A2_RAT 8 8 0.0279 −1.81 ↑In control 3.5 Collagen alpha-2(I) chain OS = Rattus
norvegicus GN = Col1a2 PE = 1 SV =
3 [CO1A2_RAT,F1LS40_RAT]
Cellular response to organic
substance
TPM1_RAT 6 3 0.0049 −1.69 ↑In control 3.2 Isoform 6 of tropomyosin alpha-1 chain
OS = Rattus norvegicus GN = Tpm1
[sp|P04692-3|TPM1_RAT,sp|P04692-6|TPM1_RAT,
sp|P04692|TPM1_RAT]
Wound healing
PRELP_RAT 10 10 0.0006 −1.65 ↑In control 3.1 Prolargin OS = Rattus norvegicus GN = Prelp
PE = 2 SV = 1
Cell aging
Contaminant 15 15 0.0054 −1.61 ↑In control / gi|547748|sp|P35527| K1CI_HUMAN
KERATIN, TYPE I CYTOSKELETAL 9 (CYTOKE
TPM4_RAT 3 1 0.0110 −1.51 ↑In control 2.9 Tropomyosin alpha-4 chain OS = Rattus
norvegicus GN = Tpm4 PE = 1 SV = 3
Cellular component
movement
PGS1_RAT 3 3 0.0227 −1.49 ↑In control 2.8 Biglycan OS = Rattus norvegicus
GN = Bgn PE = 2 SV = 1
Blood vessel remodeling
PTGR1_RAT 2 2 0.0054 −1.45 ↑In control 2.7 Prostaglandin reductase 1 OS = Rattus
norvegicus GN = Ptgr1 PE = 2 SV = 3
Response to toxic substance
K1C14_RAT 4 2 0.0039 −1.38 ↑In control 2.6 Keratin, type I cytoskeletal 14 OS = Rattus
norvegicus GN = Krt14 PE = 2 SV = 1
Response to ionizing
radiation
HS90B_RAT 6 3 0.0038 −1.37 ↑In control 2.6 Heat shock protein HSP 90-beta OS = Rattus
norvegicus GN = Hsp90ab1 PE = 1 SV = 4
Response to unfolded
protein
K1C13_RAT 17 12 0.0109 −1.29 ↑In control 2.4 Keratin, type I cytoskeletal 13 OS = Rattus
norvegicus GN = Krt13 PE = 2 SV = 1
Response to radiation
MLRS_RAT 10 10 0.0312 −1.28 ↑In control 2.4 Myosin regulatory light chain 2, skeletal
muscle isoform OS = Rattus norvegicus
GN =Mylpf PE = 2 SV = 2
Immune response,
ENOB_RAT 10 2 0.0005 −1.25 ↑In control 2.4 Beta-enolase OS = Rattus norvegicus
GN = Eno3 PE = 1 SV = 3
Aging, skeletal muscle tissue
regeneration
A2MG_RAT 5 5 0.0110 −1.25 ↑In control 2.4 Alpha-2-macroglobulin OS = Rattus
norvegicus GN = A2m PE = 2 SV = 2
[A2MG_RAT,M0R9G2_RAT]
Inﬂammatory response
MDHC_RAT 4 4 0.0028 −1.11 ↑In control 2.2 Malate dehydrogenase, cytoplasmic OS = Rattus
norvegicus GN =Mdh1 PE = 1 SV = 3
Tricarboxylic acid cycle
K2C4_RAT 10 9 0.01911 −1.11 ↑In control 2.2 Keratin, type II cytoskeletal 4 OS= Rattus norvegicus
GN = Krt4 PE = 2 SV = 1
Epithelial cell differentiation
PRVA_RAT 5 5 0.0240 −1.09 ↑In control 2.1 Parvalbumin alpha OS = Rattus norvegicus GN =
Pvalb PE = 1 SV = 2
Cytosolic calcium ion
homeostasis
Abbreviations: PC—peptide count-number of identiﬁed peptides; PQ—number of peptides that are used for quantitation.
Table 3
Subcellular localization of total 96 deregulated proteins between groups.
Cytoplasm Secreted Membrane Intermediate
ﬁlaments
Organelles Hb
complex
AL3A1, VAT1, HS90B, K1C13, F1LMU0,
F1LRV9, TPM4, F1LPQ5, TPM2, CAH1,
LEG5, GSTM1, PRDX2, SODC, WDR1,
D4AC23, KPYM, TERA, RAN, TBA1A,
HNRPK, IF4A2, ENO3, G6PI, CAH2, NDRG1,
D3ZAY2, GBB1, 1433 T, KCRM, MDHC,
PRVA,
DPYL2, B5DF65, HNRPK, ACTS, ANXA5,
D3ZER2, FABP5, EF2, PGAM1, CRBB1,
CRGD, CRBS
PRELP, PGS2, LUM, FMOD,
D3Z9F8, D3ZVD7, D3ZVB7,
PRELP, CO1A2, PGS1, CO1A2,
FIBG, APOA1, A1M, D4A111,
D3ZUL3, ALBU, ANXA5
MLRS, F8WFT7, DPYL2,
ENO3, G6PI, CAH2,
NDRG1,D3ZAY2, AT2A1,
B5DF65, ANXA5,
F1M8F1, D3ZER2
K2C5, D4A931,
K2C6A, K1C15,
K2C4, MYL1,
F1M8F1,
D3ZER2
PTGR1, A2MG, F8WG17, KPYM, TERA,
G3P, RAN, TBA1A, HNRPK, DPYL2,
D3ZVK7, D3ZIU9, PRVA, B5DF65,
G3V6H9, HNRPK, ANXA5, CRGD, CRBS
(nucleus),
M0R6J6, F1M8F18 (mitochondrion),
Q8SEZ5 (mitochondrial inner
membrane), PTGR1 (Golgi)
HBA,
HBB1,
HBB2,
Q63910,
Q62669,
O88752
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Fig. 1. A) RepresentativeWestern blot pictures showing galectin 5, biglycan, lumican,α-tubulin and Src kinase (pY529) expression. B) Densitometric analysis of signals for each group in
comparison with α tubulin expressed as experimental average ± standard deviation. Galectin 5 is strongly up-regulated in UVB group in comparison with control group. Expression of
biglycan was detected only in the control group. Lumican and Src kinase (pY529) relative expression status has the highest mean in control and the lowest in UVB treated group. Statis-
tically signiﬁcant changes in relative expressions (p b 0.05) is indicated by an asterisk (*) and correspond to the following values: Galectin 5 (p= 0.025), Src kinase (p= 0.044), Lumican
(p = 0.030).
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dephosphorylation of Y529 will modify its conformation to an open ac-
tive state. Our targeted study by Western blot revealed that UV expo-
sure led to a decrease in pY529, particularly in UVB exposed retinas
(Fig. 1), which clearly points to UVB induced activation of Src kinase
in neural retina, and suggests that speciﬁc signaling linking an extracel-
lular stimulus with intracellular events may account for photoreceptor
degeneration characteristic for AMD (Fig. 2).
5. Discussion
There is a growing body of evidence that cumulative long-term ex-
posure to UV radiation may be harmful to the retina and possibly lead
to age-related macular degeneration (AMD), the major cause of blind-
ness in the elderly population in developed countries [21,22]. Clinical
practice has shown that UVB is more damaging in comparison with
UVA, because it has a higher energy. UVB is mostly absorbed by the cor-
nea and lens of the eye. However, if exposed to UVB, the retina can be
damaged as well. UVA radiation has lower energy but can penetrate
much deeper into the eye and may also exert detrimental effects. In
spite ofmany research efforts, cellular andmolecular mechanisms lead-
ing to UV-induced retinal damage and possibly retinal diseases such as
AMD are not completely understood. Previous studies in animal models
have demonstrated the ability of UV irradiation to cause damage resem-
bling the changes seen in human AMD. In the present study, we sought
to explore damagemechanisms accounting for UV-induced retinal pho-
totoxicity in rats exposed to UVA and UVB irradiation using a proteo-
mics approach.
Our data revealed that UVA and in particular UVB irradiation caused
severe disruption of retinal metabolism, speciﬁcally reduced metabolic
activity and deregulated cellular energy homeostasis, as could be in-
ferred from down-regulation of enzymes involved in glycolysis (beta-
enolase, 6-phosphofructokinase), ATP production (creatine kinase M-
type, cytochrome c oxidase subunit 2, ATP synthase subunit beta mito-
chondrial) and citric acid cycle (malate dehydrogenase, aconitate
hydratase) in the retina of the rats after UV irradiation. Glycolysis, a
form of energy metabolism that converts glucose to lactate, constitutes
the major source of cellular ATP in the retina. Inhibition of glycolysis
could be potentially harmful to retinal cells since more than 50% of ret-
inal ATP is produced by the glycolytic pathway [23]. Glycolysis occurs in
Müller cells and photoreceptors. Chung et al. [24] reported on the sup-
pression of genes encoding several glycolytic pathway-linked enzymessuch as enolases (ENO1 and−2) in areas of Müller cell loss, which ap-
peared mainly to be due to loss of photoreceptor inner and outer seg-
ments. Photoreceptor dysfunction and death, one of the hallmarks of
AMD, could result from the inability of Müller cells to produce energy
supply for photoreceptors by glycolysis. A similar study suggests that
decreased pyruvate kinase activity in the process of glycolysis, which
may inhibit ATP production, may be associated with the pathogenesis
of AMD [23].
It has been previously shown that short wavelength radiation and
the blue light induce signiﬁcant oxidative stress to the retinal pigment
epithelium [25]. Oxidative and radical damages can alter functions of
metabolic enzymes such as creatine kinase (CK), whose expression
was reduced in both, UVA and UVB exposed rat retina. Oxidative stress
in tissues can further induce the release of Fe3+ from its storage pro-
teins that serves as a catalyst for free radical reactions, which enhances
CK inactivation [26]. Furthermore, oxidative stress can induce inhibition
of glycolysis in the retina, and this effect can be antagonized by pyru-
vate, which has the dual properties of acting as ROS scavenger and stim-
ulating tissue metabolism through acceleration of glycolysis [27].
Additional evidence for the involvement of oxidative stress in UV-
radiation induced retinal damage similar to that found in AMD ema-
nates from identiﬁcation of several proteins associated with cellular re-
sponse to oxidative stress that were over-expressed in exposed versus
control retina. Mass spectrometry analysis revealed an increase in the
expression levels of glutathione S-transferase, peroxiredoxin-2, super-
oxide dismutase and catalase only in UVB exposed retina, and reduced
levels of aldehyde dehydrogenase in retina exposed to both types of
UV irradiation. Ultraviolet radiation, mainly UVB can induce a variety
of mutagenic and cytotoxic DNA lesions. One typical structural change
is the formation of thymine dimers, the most abundant DNA lesion fol-
lowing direct UV exposure. On contrary, UVA radiation has a poor efﬁ-
ciency in inducing DNA damage, because it is not absorbed by the
native DNAmolecule [28]. In line with this, up-regulation of the protein
speciﬁcally involved in cellular response to DNA damage was detected
in UVB exposed but not in UVA exposed retina, namely the NDRG1 pro-
tein [29]. Our data suggest that UVA and UVB induce different extent of
oxidative stress resulting in the activation of speciﬁc anti-oxidant
responses.
Interestingly, we found increased levels of serum albumin in UVA
and UVB treated retinas. Previously, Nicolas et al. [30] found albumin
to be markedly increased in the whole retina of the monkeys with
early onset macular degeneration compared with normal controls.
Fig. 2. Quantitative schematic of theoretical subcellular localization for identiﬁed up-regulated proteins in A) UVA and B) UVB light treated group of animals determined by the use of
UniProt database (http://www.uniprot.org/).
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relative concentrations of albumin in the plasma samples of affected
and normal monkeys. These results suggest that up-regulation of albu-
min expressionmay be a biomarker for UV-induced pathological chang-
es in the retina reminiscent of those found in AMD. Since advanced
glycation end-products-albumin promotes death of neuronal cells in
primary culture [31], future work should be directed towards glycan
analysis of albumin in UV-exposed rat retinas to establish whether the
pathological changes in the retina induced by UV irradiation that
share common clinical features with AMD could be associated with ab-
errant albumin glycosylation.
The communication between retinal pigment epithelial cells and
photoreceptor cells is essential for visual function, as it determines the
ability of photoreceptor cells to detect light. In vertebrates, the photore-
ceptors are separated from retinal pigment epithelium (RPE) by the
subretinal space, which contains an extracellular material referred to
as interphotoreceptor matrix (IPM) specialized to enable interaction
between the RPE and the light sensitive outer segments of thephotoreceptors. Glycoconjugates in the IPM play a number of important
roles in the interactions between photoreceptors, retinal pigment epi-
thelium (RPE) cells, and Müller cells, including mediation of adhesion,
phagocytosis, outer segment stability, nutrient exchange, development,
and vitamin A trafﬁcking in the visual cycle. Our data clearly showed
that both, UVA and UVB elicit remodeling and possibly degradation of
the IPM, as we observed down-regulation of the components of the
IPM including several different collagen types and collagen-binding
proteoglycans such as prolargin, decorin, biglycan, ﬁbromodulin and
lumican in UVA and UVB exposed rat retinas. Small leucine-rich proteo-
glycans decorin, biglycan, ﬁbromodulin and lumican bind collagen type
I and regulate collagen ﬁbril structure. In mice models with kainic acid-
induced retinal degeneration, loss of inner retinal cells occurred accom-
panied by strong immunostaining for decorin and ﬁbromodulin across
the retina, while immunostaining for biglycan was weak in both the
normal retina and the retina after KA injection [32]. The same study sug-
gests that decorin and ﬁbromodulin play key roles in retinal differenti-
ation, and contribute to the retinal damage and repair process, while
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opment or repair process [32]. Ali et al. detected diffuse distribution of
biglycan in the retina and optic nerve with intense staining in nerve-
ﬁber rich layers in postnatal and adult mice [33]. Similarly, our study
conﬁrmed the expression of biglycan in control rat retina and revealed
complete loss of its expression after UVA and UVB exposures, which im-
plies that biglycan can be considered a phototoxicity biomarker for UV
radiation whose depletion may be associated with UV-induced damage
of optic nerve.
Lumican, one of the major keratan sulfate proteoglycans within the
corneal stroma, is critical for corneal clarity bymaintaining the structure
of collagen ﬁbrils which are indispensible for keeping the cornea trans-
parent [34]. It has been demonstrated that loss of lumican causes dereg-
ulation of collagen ﬁbril assembly and corneal opaciﬁcation in the
lumican null mice [35]. Similar studies in mice from other groups also
showed that null mutations in one or both alleles of the lumican gene
result in signiﬁcant defects in scleral collagen ﬁbril formation that
could lead to alterations in ocular shape and size and severely affect vi-
sion [36]. Chakravarti et al. [37] demonstrated that lumican has a key
role in the posterior stroma in maintaining normal ﬁbril architecture
by regulating ﬁbril assembly and maintaining optimal content of
keratan sulfate required for transparency. In addition to regulating the
collagen ﬁbril architecture, lumican also facilitates neutrophil recruit-
ment and invasion following corneal damage and inﬂammation [38].
Furthermore, Kao et al. [39] found that the corneal phenotypes (opacity,
perturbed ﬁbrillogenesis and thin corneal stroma) in the lumican
knockout animals develop not only as the result of the absence of
lumican expression, but also as the result of concomitant decrease in
keratocan expression in the stroma of Lum−/−mice, which suggests di-
rect regulation of keratocan expression in response to lumican abun-
dance. Indeed, we found decreased expression levels of keratocan in
UVA and UVB exposed retinas and detected statistically signiﬁcant de-
cline in lumican expression levels in UVB treated retina, which strongly
supports the idea that deregulation of lumican expression is linkedwith
impaired structural integrity and functioning of the IPM as a conse-
quence of UVB exposure. Since it was previously shown that lumican
may have a role in modulating corneal epithelial wound healing de-
pending on its state of glycanation [39], it would be interesting to deter-
mine which glycosylation patterns (speciﬁc glycan structures) in
lumican molecule are associated with collagen ﬁbril matrix defects in-
duced by UVB.
The cytoskeleton has been implicated in many aspects of vision
ranging from structural maintenance of photoreceptors to protein traf-
ﬁcking between the inner segment and outer segment and for active
transport in the connecting cilium [40]. Narimatsu et al. [41] demon-
strated that light exposure to themice caused disruption of the actin cy-
toskeleton of RPE via oxidative stress. Previous studies have shown that
reactive oxygen species stimulate the activity of Src tyrosine kinase,
which regulates the behavior and organization of the actin cytoskeleton
and affects cell migration. Cachafeiro et al. [42] reported on the marked
activation of Src kinase 6 h after exposure to high-intensity of light in
the eye-cup (at the apical side of the RPE) and in the neural retina,
and suggested that this mechanism accounts for photoreceptor cell
death. Similarly, we showed that UVB exposure activates Src kinase in
the rat retina, which triggers cytoskeletal signaling events that drive re-
modeling anddisintegration of cytoskeleton, as evident frommass spec-
trometry data showing down-regulation of several protein components
of cytoskeletal intermediate ﬁlaments (keratin types I and II) as well as
those responsible for cell movement of muscle and non-muscle cells
(including cell division), the so calledmolecularmotors such asmyosins
(e.g. Myosin light polypeptide 6,Myosin-4, Myosin light chain 1/3, skel-
etal muscle isoform, Myosin regulatory light chain 2) in both, UVA and
UVB treated retinas.
Ghalayini et al. also demonstrated that in vivo light exposure acti-
vates Src tyrosine kinase which binds to photoreceptor rod outer seg-
ment membranes in the rat retina, and suggested that light-inducedtyrosine phosphorylation could promote protein trafﬁcking from the
inner to the outer segment, which may be important for the mainte-
nance of functional or structural polarization of photoreceptor cells
[43]. Based on our data and previous ﬁndings, we propose that pharma-
cological inhibition of Src kinase could prove helpful in ameliorating
detrimental effects of light-induced oxidative stress in the retina
by preventing down-stream signaling that propels degeneration of
photoreceptors.
Crystallins and in particular Alpha-crystallin are major structural
proteins of the lens [44,45]. A recent study showed that Crystallins
may play a critical role in the protection against oxidative stress and ret-
inal degeneration [46]. In our study we were similarly able to observe
the involvement of Gamma-crystallin D in retinal structural changes in-
duced by UVA and UVB. Gamma-crystallin D can form insoluble aggre-
gates in the lens which block the passage of light through the lens to
reach the photoreceptors in the retina accounting for the clouding of
the lens in the eye known as a cataract. It has been suggested that UV
light induces thermal and photochemical reactions to the aromatic res-
idues in crystallinswhich impairs their folding and stability and contrib-
utes to cataractogenesis [47]. Moran et al. found that UVB irradiation of
Gamma-crystallin D leads to structurally speciﬁcmodiﬁcations and pre-
cipitation via two mechanisms including amorphous aggregates and
amyloid ﬁbers, and suggested that these amyloid ﬁbers could form via
side chain damage, polypeptide crosslinking, or fragmentation [48]. In
light of these ﬁndings, it would be interesting to determine the possible
structural changes of Gamma-crystallin D in treated retinas and corre-
late them with different magnitude of biological effects observed be-
tween UVA and UVB lights.
Galectins are a protein family initially identiﬁed as galactoside-
binding lectins in extracts of vertebrate tissue [49], that can interact
with glycoconjugates on or around cells and thus regulate different bio-
logical processes including adhesion, migration, chemotaxis, prolifera-
tion, apoptosis, and neurite elongation. These molecules have been
implicated in retinal adhesion and photoreceptor cell survival. Uehara
et al. [50] proposed the possible role of galectin-1 in adhesion of
the photoreceptor and outer plexiform layers by interacting with
glycoconjugates containing beta-galactoside residues in the
interphotoreceptor matrix and synaptic cleft matrix. The same authors
postulated that galectin-3may increase inMüller cells of a degenerative
rat retina, probably through endogenous anti-apoptosis. Galectin-5,
found only in rodents, was signiﬁcantly up-regulated in the retinas of
rats exposed to both, UVA and UVB irradiation, which was additionally
conﬁrmed byWestern blot analysis. Due to the lack of human counter-
parts of galectin-5, its biological role is currently difﬁcult to assess. How-
ever, one cannot rule out the possible role of galectin-5 in retinal
regeneration after UV-induced damage based on previous studies in
mice showing the ability of some galectins (namely galectins 3 and
7) to facilitate re-epithelialization of corneal wounds and regulate cor-
neal epithelial cell migration [51,52]. It seems that interaction between
galectins and the ECM components plays a crucial role in this process, as
galectin-3 is likely to mediate corneal regeneration via binding to and
regulating the function of several ECM proteins including lumican
[51], the latter identiﬁed in our study.
In conclusion, our study showed that UV irradiation induces
profound changes in the retinal proteome of the rats associated
with the disruption of energy homeostasis, oxidative stress, DNA
damage response and structural and functional impairment of the
interphotoreceptor matrix components and their cell surface receptors
such as galectins. Speciﬁcally, two small leucine-rich proteoglycans,
namely biglycan and lumican, were identiﬁed as phototoxicity bio-
markers associated with UV-induced disruption of interphotoreceptor
matrix. In addition, UVB induced activation of Src kinase, which could
account for cytoskeletal rearrangements in the retina of the rats ob-
served at the proteomics level. Compromised structural integrity of
the RPE cells and/or interphotoreceptormatrix could directly contribute
to the photoreceptor cell dysfunction and death, a major hallmark of
1844 S. Kraljević Pavelić et al. / Biochimica et Biophysica Acta 1852 (2015) 1833–1845AMD. Therefore, pharmacological intervention either to target Src ki-
nase with aim of preventing cytoskeletal rearrangements in the RPE
and neuronal retina or to help rebuild damaged IPM may provide
fresh avenues of treatment for patients suffering from AMD.
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